MEI Pharma, Inc.
Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acr- ylamide and uses thereof

Last updated:

Abstract:

Crystalline polymorph forms of 3-[2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acry- lamide are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of diseases and conditions are also presented.

Status:
Grant
Type:

Utility

Filling date:

1 May 2017

Issue date:

21 Apr 2020